3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Burkitt Lymphoma
20
Leukemia, Biphenotypic, Acute
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Recurrence
3
Leukemia
3
Neoplasm, Residual
2
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Down Syndrome
1
Blast Crisis
1
Interventions
rozanolixizumab
5
ravulizumab
5
zilucoplan
4
fludarabine
3
Cyclophosphamide
3
telitacicept
2
inebilizumab
2
talquetamab
1
remibrutinib
1
iptacopan
1
efgartigimod alfa
1
Therapeutics
1
Prednisone
1
Prednisolone
1
Plasma Exchange
1
Immunoglobulins, Intravenous
1
HBM9161
1
Cladribine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myasthenia Gravis
×
blinatumomab
×
90 days
×
Clear all
No trials found.